000117150 001__ 117150
000117150 005__ 20240319080955.0
000117150 0247_ $$2doi$$a10.5114/ADA.2022.113616
000117150 0248_ $$2sideral$$a128653
000117150 037__ $$aART-2022-128653
000117150 041__ $$aeng
000117150 100__ $$aKobusiewicz, A.
000117150 245__ $$aBody dysmorphic disorder in patients with acne: treatment challenges
000117150 260__ $$c2022
000117150 5060_ $$aAccess copy available to the general public$$fUnrestricted
000117150 5203_ $$aBody dysmorphic disorder (BDD) is defined as a constant preoccupation with one or more non-existent or slight defects or flaws in the physical appearance, often resulting in repetitive behaviours like mirror checking and camouflaging. The prevalence is around 2% in the general population with up to 10% in dermatology patients. The prevalence of BDD in patients with acne ranges between 9% and 15%. BDD is associated with considerable psychosocial deterioration, poor quality of life, and development of comorbid mental health disorders, including obsessive compulsive disorder, depression, social anxiety and alcohol or illicit drug use. Such patients suffer tremendously and are at high risk of suicide. The rate of suicidal ideation reaches 79.5%. Of this number, nearly 27.6% make failed suicidal attempts each year and 0.3% of these attempts are successful...
000117150 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-sa$$uhttp://creativecommons.org/licenses/by-nc-sa/3.0/es/
000117150 590__ $$a1.4$$b2022
000117150 592__ $$a0.384$$b2022
000117150 591__ $$aDERMATOLOGY$$b59 / 70 = 0.843$$c2022$$dQ4$$eT3
000117150 593__ $$aImmunology and Allergy$$c2022$$dQ3
000117150 591__ $$aALLERGY$$b25 / 28 = 0.893$$c2022$$dQ4$$eT3
000117150 593__ $$aDermatology$$c2022$$dQ3
000117150 594__ $$a2.3$$b2022
000117150 655_4 $$ainfo:eu-repo/semantics/other$$vinfo:eu-repo/semantics/publishedVersion
000117150 700__ $$0(orcid)0000-0003-1917-6906$$aTomás-Aragonés, L.
000117150 700__ $$0(orcid)0000-0001-5632-0351$$aMarrón, S. E.$$uUniversidad de Zaragoza
000117150 700__ $$aZalewska-Janowska, A.
000117150 7102_ $$11007$$2183$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cÁrea Dermatología
000117150 773__ $$g39, 1 (2022), 221-222$$pPostepy Dermatologii i Alergologii$$tPostepy Dermatologii i Alergologii$$x1642-395X
000117150 8564_ $$s80659$$uhttps://zaguan.unizar.es/record/117150/files/texto_completo.pdf$$yVersión publicada
000117150 8564_ $$s2516436$$uhttps://zaguan.unizar.es/record/117150/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000117150 909CO $$ooai:zaguan.unizar.es:117150$$particulos$$pdriver
000117150 951__ $$a2024-03-18-13:34:10
000117150 980__ $$aARTICLE